We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

31 hedge funds and large institutions have $12.8M invested in Dare Bioscience in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 4

41% more capital invested

Capital invested by funds: $9.12M → $12.8M (+$3.71M)

0.04% more ownership

Funds ownership: 0.73% → 0.77% (+0.04%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less funds holding

Funds holding: 36 → 31 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
31
Holders Change
-5
Holders Change %
-13.89%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
15
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$324K
2
FFS
Founders Financial Securities
Maryland
+$280K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$119K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$77K
5
UBS Group
UBS Group
Switzerland
+$64.1K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$311K
2
FFA
Founders Financial Alliance
North Carolina
-$126K
3
HighTower Advisors
HighTower Advisors
Illinois
-$41.2K
4
GCP
GSA Capital Partners
United Kingdom
-$40K
5
XT
XTX Topco
Cayman Islands
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
FFS
1
Founders Financial Securities
Maryland
$5.27M +$280K +20,360 +236%
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.53M +$34.7K +2,525 +0.9%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$819K +$119K +8,641 +14%
BlackRock
4
BlackRock
New York
$709K -$6.3K -459 -0.8%
Renaissance Technologies
5
Renaissance Technologies
New York
$650K +$324K +23,617 +77%
SAM
6
Soviero Asset Management
New York
$615K – – –
State Street
7
State Street
Massachusetts
$226K +$4.12K +300 +2%
Millennium Management
8
Millennium Management
New York
$173K -$311K -22,649 -61%
Northern Trust
9
Northern Trust
Illinois
$162K – – –
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$126K +$77K +5,609 +115%
VF
11
Virtu Financial
New York
$68K +$17.6K +1,285 +29%
IVM
12
InterWest Venture Management
California
$62K – – –
UBS Group
13
UBS Group
Switzerland
$57K +$64.1K +4,666 +11,110%
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$43K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$42K +$35.6K +2,594 +299%
Charles Schwab
16
Charles Schwab
California
$31K – – –
RJFSA
17
Raymond James Financial Services Advisors
Florida
$30K – – –
HighTower Advisors
18
HighTower Advisors
Illinois
$26K -$41.2K -3,000 -58%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$26K +$728 +53 +3%
CIBC Private Wealth Group
20
CIBC Private Wealth Group
Georgia
$25K – – –
TRCT
21
Tower Research Capital (TRC)
New York
$25K +$343 +25 +1%
Osaic Holdings
22
Osaic Holdings
Arizona
$25K +$3.43K +250 +14%
Morgan Stanley
23
Morgan Stanley
New York
$18K +$17.2K +1,250 +566%
UCFA
24
United Capital Financial Advisors
Texas
$16K – – –
ASN
25
Advisory Services Network
Georgia
$15K -$2.29K -167 -12%
1
2

DARE Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2022, worth a combined $12.8M — up 41% from $9.12M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of DARE and 2 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 15 added.

The largest buyer was Renaissance Technologies, adding an estimated $324K. The largest seller was Millennium Management, cutting an estimated $311K.

  • 31 institutional investors held Dare Bioscience (DARE) as of Q3 2022, down from 36 in Q2 2022.
  • Funds reported $12.8M of Dare Bioscience stock for Q3 2022, up 41% quarter-over-quarter.
  • 2 funds opened new Dare Bioscience positions in Q3 2022 and 7 closed out, a net change of -5 holders.
  • The largest Dare Bioscience buyer in Q3 2022 was Renaissance Technologies, an estimated $324K added.
  • The largest Dare Bioscience seller in Q3 2022 was Millennium Management, an estimated $311K sold.

Based on aggregated 13F filings for Q3 2022.